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Effects of somatostatin on calcitonin and ectopic A C T H release 
in a patient with medullary thyroid carcinoma * 
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The association of a ca lc i ton in-producing tumor w i t h ectopic A C T H product ion is rare.— 
A l t h o u g h the importance o f somatostatin (SRIF) in modula t ing the secretion of a variety of 
polypeptide hormones has been amply demonstrated, there is so far no informat ion about the 
influence o f SRIF on ca lc i ton in (CT) and ectopic A C T H release. 
Therefore we studied a 38-year-old man who had two weeks p r io r to our investigations 
undergone tota l resection of his goiter because of medul lary thy ro id carcinoma ( M C T ) . H e 
complained about rapid weight loss, diffuse abdominal pain, dyspnea, profuse diarrhea and 
muscular cramps. B l o o d pressure was elevated and a nonregional spread of the M T C in the liver 
and in a variety of l y m p h nodes diagnosed. A l t h o u g h immediate combined chemotherapy was 
started, the patient died t w o months later due to massive visceral dissemination of the tumor . A 
pos tmortem examinat ion was refused. 
The ma in laboratory findings postoperatively were the fo l lowing : The mean serum CT-levels 
were extremely elevated (about 40 ng/ml) . Serum calcium was low no rma l (4.5 mEq/1); serum 
phosphorus was normal . Serum K H " :2.4 mEq/1 and N a + : 148 mEq/1; ur inary excretion i n 24 h for 
Κ + was 90 m E q and for N a + " 60 m E q . The arterial b l o o d gases (mm Hg) were: p 0 2 66, p C 0 2 
53; pFI 7.57; base excess + 2 2 . Basal serum Cortisol was 86^ig/100ml, after exogenous A C T H 
67 ng/100 m l and after dexamethasone (2 mg) 64 μg /100 m l . Plasma renin activity was completely 
suppressed due to a tenfold increase of serum corticosterone (13.4 μ§ /100 ml) w i t h increased 
ur inary excretion of t e t r a h y d r o - D O C glucuronide (Dr . Vecsei, Heidelberg). U r i n a r y aldosterone 
excretion, however, was very low. The basal plasma A C T H levels were markedly elevated ( in i ­
t ial ly a round 1 ng/ml , increasing w i t h i n 8 weeks up to 20 ng/ml) , both w i t h radioimmunoassay 
and w i t h bioassay. There was no decrease of plasma A C T H under 8 m g dexamethasone for t w o 
days. The common association of M C T wi th pheochromocytoma could be excluded in our 
patient by the normal values of metanephrine and vani l lylmandel ic acid. L o w potassium and 
glucocor t icoid excess led to an overt diabetes melli tus w i t h hypoinsulinemia. A n addi t ional 
overproduct ion of vaso- inhib i tory peptide (VIP) could be excluded by no rma l serum V I P values 
(Dr . Bloom, London) , a l though profuse diarrhea, low potassium, low gastric acid output after 
pentagastrin s t imula t ion and elevated basal gastrin values (175pg/ml) were in i t ia l ly thought to 
be due to a Ve rne r -Mor r i son syndrome. Increased serotonin produc t ion as cause for the gas­
trointestinal symptoms cou ld also not be shown. 











- 15 41 — 18 163 before SRIF 
0 48 20.48 19 129 
15 13 17.25 7 1202 during SRIF 
30 17 4.93 9 1297 
60 35 2.12 12 915 
90 80 2.60 9 729 
120 96 1.53 14 557 
150 81 2.54 26 556 after SRIF 
180 33 1.23 31 486 
49 
The influence otSRIF on calci tonin and A C T H release was tested using 250 pg SRIF (i.v.) as 
a bolus followed by a two-hour infusion w i t h 500 ng. The effectiveness of the inhib i tory action of 
SRIF could be demonstrated by the insulin release pattern as shown in the Table. C T decreased 
in i t ia l ly , followed by a marked increase dur ing SRIF infusion. A C T H could be markedly sup­
pressed, followed by a slight rebound after removal of SRIF . There was a so far unexplainable 
paradoxical rise of prolact in under SRIF . G r o w t h hormone and T S H were already completely 
suppressed by the glucocort icoid excess and thyro id hormone therapy, respectively. 
Conclusion: The inh ib i to ry effect of SRIF is only briefly or not observed on C T secretion, as 
shown in this patient and further confirmed by the study o f a second patient wi th Μ CT [ 1 ] . I n 
contrast, ectopic A C T H was diminished markedly dur ing the infusion of SRIF . The same pheno­
menon could be demonstrated in patients w i t h p i tu i ta ry A C T H excess [2]. Therefore SRIF 
cannot be regarded as a too l for C T reduct ion, whereas disorders wi th A C T H excess might be 
therapeutically influenced by SRIF . 
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